← 產業報告目錄
Recombinant Antibody Expression Service Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 138報告編號 APO-55e1211aed
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Recombinant Antibody Expression Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Recombinant Antibody Expression Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Recombinant Antibody Expression Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Recombinant Antibody Expression Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Recombinant Antibody Expression Service include GenScript Biotech, Creative Biolabs, Thermo Fisher Scientific, Bio-Rad Laboratories, Sino Biological, ProMab Biotechnologies, LakePharma(Curia), Profacgen and Atlas Antibodies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Recombinant Antibody Expression Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Recombinant Antibody Expression Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Recombinant Antibody Expression Service Market by Company
GenScript Biotech
Creative Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories
Sino Biological
ProMab Biotechnologies
LakePharma(Curia)
Profacgen
Atlas Antibodies
Absolute Antibody
ProteoGenix
Rockland Immunochemicals
Proteintech
RayBiotech
BioLegend
Agilent Technologies
Novus Biologicals
OriGene Technologies
ACROBiosystems
Fitzgerald Industries(Biosynth)
Azenta Life Sciences
R&D Systems
Abnova
WuXi Biologics
Biointron Biological
Detai Bio-Tech
cusabio
FITGENE
GentleGen
TekBiotech
Recombinant Antibody Expression Service Segment by Type
Recombinant Protein Mammalian Expression Service
Chimeric Antibody Expression Service
Recombinant Fragment Antibody Expression Service
VHH Nanobody Expression Service
Recombinant Antibody Expression Service Segment by Application
Scientific Research
Immunodiagnostics
Antibody Drug Development
Others
Recombinant Antibody Expression Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Antibody Expression Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Recombinant Antibody Expression Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Antibody Expression Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Recombinant Antibody Expression Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Recombinant Antibody Expression Service by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Recombinant Protein Mammalian Expression Service
2.2.3 Chimeric Antibody Expression Service
2.2.4 Recombinant Fragment Antibody Expression Service
2.2.5 VHH Nanobody Expression Service
2.3 Recombinant Antibody Expression Service by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Scientific Research
2.3.3 Immunodiagnostics
2.3.4 Antibody Drug Development
2.3.5 Others
2.4 Assumptions and Limitations
3 Recombinant Antibody Expression Service Breakdown Data by Type
3.1 Global Recombinant Antibody Expression Service Historic Market Size by Type (2021-2026)
3.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2027-2032)
4 Recombinant Antibody Expression Service Breakdown Data by Application
4.1 Global Recombinant Antibody Expression Service Historic Market Size by Application (2021-2026)
4.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Recombinant Antibody Expression Service Market Perspective (2021-2032)
5.2 Global Recombinant Antibody Expression Service Growth Trends by Region
5.2.1 Global Recombinant Antibody Expression Service Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Recombinant Antibody Expression Service Historic Market Size by Region (2021-2026)
5.2.3 Recombinant Antibody Expression Service Forecasted Market Size by Region (2027-2032)
5.3 Recombinant Antibody Expression Service Market Dynamics
5.3.1 Recombinant Antibody Expression Service Industry Trends
5.3.2 Recombinant Antibody Expression Service Market Drivers
5.3.3 Recombinant Antibody Expression Service Market Challenges
5.3.4 Recombinant Antibody Expression Service Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Recombinant Antibody Expression Service Players by Revenue
6.1.1 Global Top Recombinant Antibody Expression Service Players by Revenue (2021-2026)
6.1.2 Global Recombinant Antibody Expression Service Revenue Market Share by Players (2021-2026)
6.2 Global Recombinant Antibody Expression Service Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Recombinant Antibody Expression Service Head Office and Area Served
6.4 Global Recombinant Antibody Expression Service Players, Product Type & Application
6.5 Global Recombinant Antibody Expression Service Manufacturers Established Date
6.6 Global Recombinant Antibody Expression Service Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Recombinant Antibody Expression Service Market Size (2021-2032)
7.2 North America Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Recombinant Antibody Expression Service Market Size by Country (2021-2026)
7.4 North America Recombinant Antibody Expression Service Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Recombinant Antibody Expression Service Market Size (2021-2032)
8.2 Europe Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Recombinant Antibody Expression Service Market Size by Country (2021-2026)
8.4 Europe Recombinant Antibody Expression Service Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Recombinant Antibody Expression Service Market Size (2021-2032)
9.2 Asia-Pacific Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Recombinant Antibody Expression Service Market Size by Country (2021-2026)
9.4 Asia-Pacific Recombinant Antibody Expression Service Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Recombinant Antibody Expression Service Market Size (2021-2032)
10.2 South America Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Recombinant Antibody Expression Service Market Size by Country (2021-2026)
10.4 South America Recombinant Antibody Expression Service Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Recombinant Antibody Expression Service Market Size (2021-2032)
11.2 Middle East & Africa Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2021-2026)
11.4 Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 GenScript Biotech
12.1.1 GenScript Biotech Company Information
12.1.2 GenScript Biotech Business Overview
12.1.3 GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.1.4 GenScript Biotech Recombinant Antibody Expression Service Product Portfolio
12.1.5 GenScript Biotech Recent Developments
12.2 Creative Biolabs
12.2.1 Creative Biolabs Company Information
12.2.2 Creative Biolabs Business Overview
12.2.3 Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.2.4 Creative Biolabs Recombinant Antibody Expression Service Product Portfolio
12.2.5 Creative Biolabs Recent Developments
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Information
12.3.2 Thermo Fisher Scientific Business Overview
12.3.3 Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.3.4 Thermo Fisher Scientific Recombinant Antibody Expression Service Product Portfolio
12.3.5 Thermo Fisher Scientific Recent Developments
12.4 Bio-Rad Laboratories
12.4.1 Bio-Rad Laboratories Company Information
12.4.2 Bio-Rad Laboratories Business Overview
12.4.3 Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.4.4 Bio-Rad Laboratories Recombinant Antibody Expression Service Product Portfolio
12.4.5 Bio-Rad Laboratories Recent Developments
12.5 Sino Biological
12.5.1 Sino Biological Company Information
12.5.2 Sino Biological Business Overview
12.5.3 Sino Biological Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.5.4 Sino Biological Recombinant Antibody Expression Service Product Portfolio
12.5.5 Sino Biological Recent Developments
12.6 ProMab Biotechnologies
12.6.1 ProMab Biotechnologies Company Information
12.6.2 ProMab Biotechnologies Business Overview
12.6.3 ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.6.4 ProMab Biotechnologies Recombinant Antibody Expression Service Product Portfolio
12.6.5 ProMab Biotechnologies Recent Developments
12.7 LakePharma(Curia)
12.7.1 LakePharma(Curia) Company Information
12.7.2 LakePharma(Curia) Business Overview
12.7.3 LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.7.4 LakePharma(Curia) Recombinant Antibody Expression Service Product Portfolio
12.7.5 LakePharma(Curia) Recent Developments
12.8 Profacgen
12.8.1 Profacgen Company Information
12.8.2 Profacgen Business Overview
12.8.3 Profacgen Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.8.4 Profacgen Recombinant Antibody Expression Service Product Portfolio
12.8.5 Profacgen Recent Developments
12.9 Atlas Antibodies
12.9.1 Atlas Antibodies Company Information
12.9.2 Atlas Antibodies Business Overview
12.9.3 Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.9.4 Atlas Antibodies Recombinant Antibody Expression Service Product Portfolio
12.9.5 Atlas Antibodies Recent Developments
12.10 Absolute Antibody
12.10.1 Absolute Antibody Company Information
12.10.2 Absolute Antibody Business Overview
12.10.3 Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.10.4 Absolute Antibody Recombinant Antibody Expression Service Product Portfolio
12.10.5 Absolute Antibody Recent Developments
12.11 ProteoGenix
12.11.1 ProteoGenix Company Information
12.11.2 ProteoGenix Business Overview
12.11.3 ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.11.4 ProteoGenix Recombinant Antibody Expression Service Product Portfolio
12.11.5 ProteoGenix Recent Developments
12.12 Rockland Immunochemicals
12.12.1 Rockland Immunochemicals Company Information
12.12.2 Rockland Immunochemicals Business Overview
12.12.3 Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.12.4 Rockland Immunochemicals Recombinant Antibody Expression Service Product Portfolio
12.12.5 Rockland Immunochemicals Recent Developments
12.13 Proteintech
12.13.1 Proteintech Company Information
12.13.2 Proteintech Business Overview
12.13.3 Proteintech Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.13.4 Proteintech Recombinant Antibody Expression Service Product Portfolio
12.13.5 Proteintech Recent Developments
12.14 RayBiotech
12.14.1 RayBiotech Company Information
12.14.2 RayBiotech Business Overview
12.14.3 RayBiotech Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.14.4 RayBiotech Recombinant Antibody Expression Service Product Portfolio
12.14.5 RayBiotech Recent Developments
12.15 BioLegend
12.15.1 BioLegend Company Information
12.15.2 BioLegend Business Overview
12.15.3 BioLegend Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.15.4 BioLegend Recombinant Antibody Expression Service Product Portfolio
12.15.5 BioLegend Recent Developments
12.16 Agilent Technologies
12.16.1 Agilent Technologies Company Information
12.16.2 Agilent Technologies Business Overview
12.16.3 Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.16.4 Agilent Technologies Recombinant Antibody Expression Service Product Portfolio
12.16.5 Agilent Technologies Recent Developments
12.17 Novus Biologicals
12.17.1 Novus Biologicals Company Information
12.17.2 Novus Biologicals Business Overview
12.17.3 Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.17.4 Novus Biologicals Recombinant Antibody Expression Service Product Portfolio
12.17.5 Novus Biologicals Recent Developments
12.18 OriGene Technologies
12.18.1 OriGene Technologies Company Information
12.18.2 OriGene Technologies Business Overview
12.18.3 OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.18.4 OriGene Technologies Recombinant Antibody Expression Service Product Portfolio
12.18.5 OriGene Technologies Recent Developments
12.19 ACROBiosystems
12.19.1 ACROBiosystems Company Information
12.19.2 ACROBiosystems Business Overview
12.19.3 ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.19.4 ACROBiosystems Recombinant Antibody Expression Service Product Portfolio
12.19.5 ACROBiosystems Recent Developments
12.20 Fitzgerald Industries(Biosynth)
12.20.1 Fitzgerald Industries(Biosynth) Company Information
12.20.2 Fitzgerald Industries(Biosynth) Business Overview
12.20.3 Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.20.4 Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Product Portfolio
12.20.5 Fitzgerald Industries(Biosynth) Recent Developments
12.21 Azenta Life Sciences
12.21.1 Azenta Life Sciences Company Information
12.21.2 Azenta Life Sciences Business Overview
12.21.3 Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.21.4 Azenta Life Sciences Recombinant Antibody Expression Service Product Portfolio
12.21.5 Azenta Life Sciences Recent Developments
12.22 R&D Systems
12.22.1 R&D Systems Company Information
12.22.2 R&D Systems Business Overview
12.22.3 R&D Systems Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.22.4 R&D Systems Recombinant Antibody Expression Service Product Portfolio
12.22.5 R&D Systems Recent Developments
12.23 Abnova
12.23.1 Abnova Company Information
12.23.2 Abnova Business Overview
12.23.3 Abnova Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.23.4 Abnova Recombinant Antibody Expression Service Product Portfolio
12.23.5 Abnova Recent Developments
12.24 WuXi Biologics
12.24.1 WuXi Biologics Company Information
12.24.2 WuXi Biologics Business Overview
12.24.3 WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.24.4 WuXi Biologics Recombinant Antibody Expression Service Product Portfolio
12.24.5 WuXi Biologics Recent Developments
12.25 Biointron Biological
12.25.1 Biointron Biological Company Information
12.25.2 Biointron Biological Business Overview
12.25.3 Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.25.4 Biointron Biological Recombinant Antibody Expression Service Product Portfolio
12.25.5 Biointron Biological Recent Developments
12.26 Detai Bio-Tech
12.26.1 Detai Bio-Tech Company Information
12.26.2 Detai Bio-Tech Business Overview
12.26.3 Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.26.4 Detai Bio-Tech Recombinant Antibody Expression Service Product Portfolio
12.26.5 Detai Bio-Tech Recent Developments
12.27 cusabio
12.27.1 cusabio Company Information
12.27.2 cusabio Business Overview
12.27.3 cusabio Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.27.4 cusabio Recombinant Antibody Expression Service Product Portfolio
12.27.5 cusabio Recent Developments
12.28 FITGENE
12.28.1 FITGENE Company Information
12.28.2 FITGENE Business Overview
12.28.3 FITGENE Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.28.4 FITGENE Recombinant Antibody Expression Service Product Portfolio
12.28.5 FITGENE Recent Developments
12.29 GentleGen
12.29.1 GentleGen Company Information
12.29.2 GentleGen Business Overview
12.29.3 GentleGen Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.29.4 GentleGen Recombinant Antibody Expression Service Product Portfolio
12.29.5 GentleGen Recent Developments
12.30 TekBiotech
12.30.1 TekBiotech Company Information
12.30.2 TekBiotech Business Overview
12.30.3 TekBiotech Revenue in Recombinant Antibody Expression Service Business (2021-2026)
12.30.4 TekBiotech Recombinant Antibody Expression Service Product Portfolio
12.30.5 TekBiotech Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Recombinant Antibody Expression Service Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2021-2026)
Table 7. Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2027-2032)
Table 9. Global Recombinant Antibody Expression Service Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2021-2026)
Table 11. Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Recombinant Antibody Expression Service Revenue Market Share by Application (2027-2032)
Table 13. Global Recombinant Antibody Expression Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Recombinant Antibody Expression Service Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Recombinant Antibody Expression Service Market Share by Region (2021-2026)
Table 16. Global Recombinant Antibody Expression Service Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Recombinant Antibody Expression Service Market Share by Region (2027-2032)
Table 18. Recombinant Antibody Expression Service Industry Trends
Table 19. Recombinant Antibody Expression Service Industry Drivers
Table 20. Recombinant Antibody Expression Service Industry Opportunities and Challenges
Table 21. Recombinant Antibody Expression Service Market Restraints
Table 22. Global Top Recombinant Antibody Expression Service Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Recombinant Antibody Expression Service Revenue Market Share by Players (2021-2026)
Table 24. Global Recombinant Antibody Expression Service Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Recombinant Antibody Expression Service, Headquarters and Area Served
Table 26. Global Recombinant Antibody Expression Service Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Recombinant Antibody Expression Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Recombinant Antibody Expression Service Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Recombinant Antibody Expression Service Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Recombinant Antibody Expression Service Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Recombinant Antibody Expression Service Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Recombinant Antibody Expression Service Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Recombinant Antibody Expression Service Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Recombinant Antibody Expression Service Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Recombinant Antibody Expression Service Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Recombinant Antibody Expression Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Recombinant Antibody Expression Service Market Size by Country (2027-2032) & (US$ Million)
Table 45. GenScript Biotech Company Information
Table 46. GenScript Biotech Business Overview
Table 47. GenScript Biotech Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 48. GenScript Biotech Recombinant Antibody Expression Service Product Portfolio
Table 49. GenScript Biotech Recent Developments
Table 50. Creative Biolabs Company Information
Table 51. Creative Biolabs Business Overview
Table 52. Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 53. Creative Biolabs Recombinant Antibody Expression Service Product Portfolio
Table 54. Creative Biolabs Recent Developments
Table 55. Thermo Fisher Scientific Company Information
Table 56. Thermo Fisher Scientific Business Overview
Table 57. Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 58. Thermo Fisher Scientific Recombinant Antibody Expression Service Product Portfolio
Table 59. Thermo Fisher Scientific Recent Developments
Table 60. Bio-Rad Laboratories Company Information
Table 61. Bio-Rad Laboratories Business Overview
Table 62. Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 63. Bio-Rad Laboratories Recombinant Antibody Expression Service Product Portfolio
Table 64. Bio-Rad Laboratories Recent Developments
Table 65. Sino Biological Company Information
Table 66. Sino Biological Business Overview
Table 67. Sino Biological Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 68. Sino Biological Recombinant Antibody Expression Service Product Portfolio
Table 69. Sino Biological Recent Developments
Table 70. ProMab Biotechnologies Company Information
Table 71. ProMab Biotechnologies Business Overview
Table 72. ProMab Biotechnologies Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 73. ProMab Biotechnologies Recombinant Antibody Expression Service Product Portfolio
Table 74. ProMab Biotechnologies Recent Developments
Table 75. LakePharma(Curia) Company Information
Table 76. LakePharma(Curia) Business Overview
Table 77. LakePharma(Curia) Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 78. LakePharma(Curia) Recombinant Antibody Expression Service Product Portfolio
Table 79. LakePharma(Curia) Recent Developments
Table 80. Profacgen Company Information
Table 81. Profacgen Business Overview
Table 82. Profacgen Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 83. Profacgen Recombinant Antibody Expression Service Product Portfolio
Table 84. Profacgen Recent Developments
Table 85. Atlas Antibodies Company Information
Table 86. Atlas Antibodies Business Overview
Table 87. Atlas Antibodies Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 88. Atlas Antibodies Recombinant Antibody Expression Service Product Portfolio
Table 89. Atlas Antibodies Recent Developments
Table 90. Absolute Antibody Company Information
Table 91. Absolute Antibody Business Overview
Table 92. Absolute Antibody Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 93. Absolute Antibody Recombinant Antibody Expression Service Product Portfolio
Table 94. Absolute Antibody Recent Developments
Table 95. ProteoGenix Company Information
Table 96. ProteoGenix Business Overview
Table 97. ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 98. ProteoGenix Recombinant Antibody Expression Service Product Portfolio
Table 99. ProteoGenix Recent Developments
Table 100. Rockland Immunochemicals Company Information
Table 101. Rockland Immunochemicals Business Overview
Table 102. Rockland Immunochemicals Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 103. Rockland Immunochemicals Recombinant Antibody Expression Service Product Portfolio
Table 104. Rockland Immunochemicals Recent Developments
Table 105. Proteintech Company Information
Table 106. Proteintech Business Overview
Table 107. Proteintech Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 108. Proteintech Recombinant Antibody Expression Service Product Portfolio
Table 109. Proteintech Recent Developments
Table 110. RayBiotech Company Information
Table 111. RayBiotech Business Overview
Table 112. RayBiotech Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 113. RayBiotech Recombinant Antibody Expression Service Product Portfolio
Table 114. RayBiotech Recent Developments
Table 115. BioLegend Company Information
Table 116. BioLegend Business Overview
Table 117. BioLegend Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 118. BioLegend Recombinant Antibody Expression Service Product Portfolio
Table 119. BioLegend Recent Developments
Table 120. Agilent Technologies Company Information
Table 121. Agilent Technologies Business Overview
Table 122. Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 123. Agilent Technologies Recombinant Antibody Expression Service Product Portfolio
Table 124. Agilent Technologies Recent Developments
Table 125. Novus Biologicals Company Information
Table 126. Novus Biologicals Business Overview
Table 127. Novus Biologicals Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 128. Novus Biologicals Recombinant Antibody Expression Service Product Portfolio
Table 129. Novus Biologicals Recent Developments
Table 130. OriGene Technologies Company Information
Table 131. OriGene Technologies Business Overview
Table 132. OriGene Technologies Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 133. OriGene Technologies Recombinant Antibody Expression Service Product Portfolio
Table 134. OriGene Technologies Recent Developments
Table 135. ACROBiosystems Company Information
Table 136. ACROBiosystems Business Overview
Table 137. ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 138. ACROBiosystems Recombinant Antibody Expression Service Product Portfolio
Table 139. ACROBiosystems Recent Developments
Table 140. Fitzgerald Industries(Biosynth) Company Information
Table 141. Fitzgerald Industries(Biosynth) Business Overview
Table 142. Fitzgerald Industries(Biosynth) Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 143. Fitzgerald Industries(Biosynth) Recombinant Antibody Expression Service Product Portfolio
Table 144. Fitzgerald Industries(Biosynth) Recent Developments
Table 145. Azenta Life Sciences Company Information
Table 146. Azenta Life Sciences Business Overview
Table 147. Azenta Life Sciences Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 148. Azenta Life Sciences Recombinant Antibody Expression Service Product Portfolio
Table 149. Azenta Life Sciences Recent Developments
Table 150. R&D Systems Company Information
Table 151. R&D Systems Business Overview
Table 152. R&D Systems Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 153. R&D Systems Recombinant Antibody Expression Service Product Portfolio
Table 154. R&D Systems Recent Developments
Table 155. Abnova Company Information
Table 156. Abnova Business Overview
Table 157. Abnova Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 158. Abnova Recombinant Antibody Expression Service Product Portfolio
Table 159. Abnova Recent Developments
Table 160. WuXi Biologics Company Information
Table 161. WuXi Biologics Business Overview
Table 162. WuXi Biologics Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 163. WuXi Biologics Recombinant Antibody Expression Service Product Portfolio
Table 164. WuXi Biologics Recent Developments
Table 165. Biointron Biological Company Information
Table 166. Biointron Biological Business Overview
Table 167. Biointron Biological Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 168. Biointron Biological Recombinant Antibody Expression Service Product Portfolio
Table 169. Biointron Biological Recent Developments
Table 170. Detai Bio-Tech Company Information
Table 171. Detai Bio-Tech Business Overview
Table 172. Detai Bio-Tech Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 173. Detai Bio-Tech Recombinant Antibody Expression Service Product Portfolio
Table 174. Detai Bio-Tech Recent Developments
Table 175. cusabio Company Information
Table 176. cusabio Business Overview
Table 177. cusabio Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 178. cusabio Recombinant Antibody Expression Service Product Portfolio
Table 179. cusabio Recent Developments
Table 180. FITGENE Company Information
Table 181. FITGENE Business Overview
Table 182. FITGENE Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 183. FITGENE Recombinant Antibody Expression Service Product Portfolio
Table 184. FITGENE Recent Developments
Table 185. GentleGen Company Information
Table 186. GentleGen Business Overview
Table 187. GentleGen Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 188. GentleGen Recombinant Antibody Expression Service Product Portfolio
Table 189. GentleGen Recent Developments
Table 190. TekBiotech Company Information
Table 191. TekBiotech Business Overview
Table 192. TekBiotech Revenue in Recombinant Antibody Expression Service Business (2021-2026) & (US$ Million)
Table 193. TekBiotech Recombinant Antibody Expression Service Product Portfolio
Table 194. TekBiotech Recent Developments
Table 195. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Recombinant Antibody Expression Service Product Image
Figure 5. Global Recombinant Antibody Expression Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Recombinant Antibody Expression Service Market Share by Type: 2025 VS 2032
Figure 7. Recombinant Protein Mammalian Expression Service Product
Figure 8. Chimeric Antibody Expression Service Product
Figure 9. Recombinant Fragment Antibody Expression Service Product
Figure 10. VHH Nanobody Expression Service Product
Figure 11. Global Recombinant Antibody Expression Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global Recombinant Antibody Expression Service Market Share by Application: 2025 VS 2032
Figure 13. Scientific Research Product
Figure 14. Immunodiagnostics Product
Figure 15. Antibody Drug Development Product
Figure 16. Others Product
Figure 17. Global Recombinant Antibody Expression Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Recombinant Antibody Expression Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Recombinant Antibody Expression Service Market Share by Region: 2025 VS 2032
Figure 20. Global Recombinant Antibody Expression Service Market Share by Players in 2025
Figure 21. Global Recombinant Antibody Expression Service Manufacturers Established Date
Figure 22. Global Top 5 and 10 Recombinant Antibody Expression Service Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 26. United States Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 29. Europe Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 31. Germany Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 41. China Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 46. Australia Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Recombinant Antibody Expression Service Market Share by Country (2021-2032)
Figure 51. Brazil Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Recombinant Antibody Expression Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. GenScript Biotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 57. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 60. Sino Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 61. ProMab Biotechnologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 62. LakePharma(Curia) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 63. Profacgen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 64. Atlas Antibodies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 65. Absolute Antibody Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 66. ProteoGenix Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 67. Rockland Immunochemicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 68. Proteintech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 69. RayBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 70. BioLegend Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 71. Agilent Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 72. Novus Biologicals Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 73. OriGene Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 74. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 75. Fitzgerald Industries(Biosynth) Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 76. Azenta Life Sciences Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 77. R&D Systems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 78. Abnova Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 79. WuXi Biologics Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 80. Biointron Biological Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 81. Detai Bio-Tech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 82. cusabio Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 83. FITGENE Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 84. GentleGen Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
Figure 85. TekBiotech Revenue Growth Rate in Recombinant Antibody Expression Service Business (2021-2026)
提及公司
GenScript BiotechCreative BiolabsThermo Fisher ScientificBio-Rad LaboratoriesSino BiologicalProMab BiotechnologiesLakePharma(Curia)ProfacgenAtlas AntibodiesAbsolute AntibodyProteoGenixRockland ImmunochemicalsProteintechRayBiotechBioLegendAgilent TechnologiesNovus BiologicalsOriGene TechnologiesACROBiosystemsFitzgerald Industries(Biosynth)Azenta Life SciencesR&D SystemsAbnovaWuXi BiologicsBiointron BiologicalDetai Bio-TechcusabioFITGENEGentleGenTekBiotech
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們